XenoPort, Inc. - Common Stock

By Business Wire 02/01/12 - 01:30 PM EST XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its fourth quarter financial results on February 14, 2012 at approximately 4:30 pm Eastern Time.

Do you think the stock market is in for a new bout of volatility? If so, you may be interested in this list. We ran a screen on the biotech industry for stocks with high liquidity, measured by current ratios above 3. Because biotech companies often ...

By Stella Mariz NuVasive, Inc. (NASDAQ:NUVA): A hearing on Medtronic's (NYSE:MDT) petition for an injunction against NuVasive (NASDAQ:NUVA) is slated to be held tomorrow, January 26.

Earlier this month, Bristol-Myers (BMY) agreed to buy Inibitex, Inc. (INHX) for $26 per share. Inhibitex surged on the news, more than doubling in a single day.

(RTTNews) - Biopharmaceutical company XenoPort, Inc. (XNPT: News ) and Japan's Astellas Pharma Inc. (ALPMY.PK, ALPMF.PK) Wednesday said that Regnite (gabapentin enacarbil) has received marketing approval in Japan for the treatment of moderate-to-severe ...